OXiGENE, Inc. (NASDAQ: $OXGN) This Is Bounce Play Land. Get Ready And Don’t Miss Out!
OXiGENE, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of product candidates that disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions.
August 10, 2010
|
Posted by Seth Wrigley
Categories:
Tags:
Recent Comments